Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer


Lymphoma research with focus on DLBCL (NGS,  pathology, DH lymphoma and treatment evaluation):Immunotherapy with focus on vaccination trial in MDS patient treated with azacytidine.

Primære forskningsområder

Lymphoma; NGS; pathology;

Immunotherapy; Myelodysplastic syndrome; vaccination

Aktuel forskning

Several projects:

Peptide vaccination trial (Fase 1-2) in patients with MDS and treated with azacytidine. In the same project we investigate new epitopes in MDS patients. It is in cooperation with KVL/DTU.

NGS project in regard to DLBCL in cooperation with an international research group grounded at Duke University in Durham. Furthermore in this cooperation we are gathering data to do NGS in all hematologic malignancies.

Mulige interessekonflikter

In regard to our peptide-vaccination trial in MDS we have an unrestricted grant from Celgene to purchase the peptides. I have received several travel grants to meetings abroad from different companies.  

ID: 32287709